NHS Framework for North of England Branded Medicines Tranche A & Annual Tranche
Estimated value
£262.0m
Awarded value
£262.0m
Suppliers
1
Lots
1
Published
14 Mar 2023
Description
NHS Framework for North of England Branded Medicines - Tranche A and Annual Tranche. Offer reference number: CM/PHR/20/5606 CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A. Period of framework: 1 March 2023 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. Period of framework: 1 March 2023 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5606/03 - NHS National Framework Agreement for the supply of Risankizumab for South of England and London. Period of framework: 1 March 2023 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months
Scope
- Reference
- CF-1314600D0O000000rwimUAA
- Total value
- £261,970,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 01 Mar 2023 to 28 Feb 2025
- CPV classifications
- 33600000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 24 Oct 2022, 12:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£262.0m
Award date
08 Feb 2023
Contract start
01 Mar 2023
Contract end
28 Feb 2025